BACKGROUND. Osteoblastic bone metastasis is the predominant phenotype observed in prostate cancer patients and is associated with high patient mortality and morbidity. However, the mechanisms determining the development of this phenotype are not well understood. Prostate cancer cells secrete several osteogenic factors including Wnt proteins, which are not only osteoinductive but also oncogenic. Therefore, the purpose of the study was to investigate the contribution of the Wnt signaling pathway in prostate cancer growth, incidence of bone metastases, and osteoblastic phenotype of bone metastases. The strategy involved overexpressing the Wnt antagonist, DKK-1, in the mixed osteoblastic and osteolytic Ace-1 prostate cancer cells. METHODS. Ace-1 prostate cancer cells stably expressing human DKK-1 or empty vector were established and transduced with lentiviral yellow fluorescent protein (YFP)-luciferase (Luc). The Ace-1/vector YFP-LUC and Ace-1/DKK-1 YFP-LUC cells were injected subcutaneously, intratibially, or in the left cardiac ventricle in athymic mice. RESULTS. Unexpectedly, DKK-1 significantly increased Ace-1 subcutaneous tumor mass and the incidence of bone metastases after intracardiac injection of Ace-1 cells. DKK-1 increased Ace-1 tumor growth associated with increased phospho46 c-Jun amino-terminal kinase by the Wnt noncanonical pathway. As expected, DKK-1 decreased the Ace-1 osteoblastic phenotype of bone metastases, as confirmed by radiographic, histopathologic, and microcomputed tomographic analysis. DKK-1 decreased osteoblastic activity via the Wnt canonical pathway evidenced by an inhibition of T-cell factor activity in murine osteoblast precursor ST2 cells. CONCLUSION. The present study showed that DKK-1 is a potent inhibitor of bone growth in prostate cancer-induced osteoblastic metastases. Prostate 71: 615-625, 2011.
INTRODUCTION
Prostate cancer patients frequently develop bone metastases in late stages of the disease [1] . Most of the bone metastases are osteoblastic resulting in excessive, but poor quality, bone formation [2, 3] . Osteoblastic metastases result in spinal cord compression, pathologic fractures, and pain resulting in severe morbidity of patients [4] . Using the Ace-1 model we previously showed that prostate cancer directly induced new bone formation in athymic mice [5, 6] . Mechanisms responsible for prostate cancer osteoblastic bone metastases are not clearly defined [7] .
Prostate cancer produces Wnt proteins, which were shown to possess tumorigenic and osteogenic potential [8] . Wnts are a large family of soluble proteins that contribute to normal development and embryogenesis [9] . However, dysregulated Wnt signaling has been implicated in the development of multiple cancer types, including prostate cancer [10] . Additionally, several Wnts were reported to be upregulated in cancers resulting in increased growth [11] [12] [13] . Wnts act through both canonical and noncanonical pathways [14] .
The canonical Wnt pathway acts by binding to low density lipoprotein receptor proteins (LRP) and frizzled receptors on target cells to induce Wnt signaling [15] . Wnt signaling dissociates the b-catenin destruction complex consisting of axin, adenomatous polyposis coli (APC), and glycogen synthase kinase 3b (GSK3b), which leads to phosphorylation of b-catenin for ubiquitination and proteosomal degradation in the cytoplasm [8] . Therefore, in the presence of Wnts, bcatenin is stabilized and translocated into the nucleus where it binds to, and activates, T-cell factor (TCF). TCF acts on downstream target genes that are important for cell survival, proliferation, and angiogenesis [16] . Consequently, upregulation of the Wnt signaling pathway was shown to promote tumor survival and progression [17] .
Wnts are important for the development and maintenance of bone by inducing the differentiation and maturation of precursor osteoblasts to active osteoblasts [18] . Secretion of Wnts in prostate cancer was also shown to play an important role in the development of osteoblastic metastases [19] . Dickkopf-1 (DKK-1) antagonizes Wnts by binding to the LRP receptor on the target cells, resulting in internalization of the receptor and inhibition of Wnt-mediated canonical signaling [15] . DKK-1 has been reported to be downregulated in prostate cancer patients in advanced stages [20] . Moreover, DKK-1 was overexpressed in breast cancer patients who develop predominantly osteolytic bone metastases [15, 21] .
Therefore, the hypothesis for this study was that inhibition of Wnt signaling by DKK-1 will decrease both prostate cancer growth in an autocrine manner and prostate cancer-induced osteoblastic metastases in a paracrine manner. To test this hypothesis, Ace-1 prostate cancer cells that develop mixed osteoblastic and osteolytic bone metastases were transfected to overexpress DKK-1. In this study, the functional role of overexpression of DKK-1 on prostate cancer growth, incidence of bone metastases, and osteoblastic phenotype of bone metastases was investigated.
MATERIALS AND METHODS

Cell Culture
The canine Ace-1 prostate cancer cells (derived from a spontaneous dog prostate carcinoma by our laboratory) [22] were maintained at 378C in Dulbecco's Modified Eagle's Medium/Ham's Nutrient Mixture F12 (DMEM/F12) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, 250 U/ml penicillin, 250 mg/ml streptomycin, and 2 mM L-glutamine (Invitrogen) in a 5% CO 2 -humidified chamber. ST-2 cells, mouse bone marrow stromal cell line, were maintained in Minimal Essential Medium Alpha (Invitrogen) supplemented with 10% fetal bovine serum, 250 U/ml penicillin, 250 mg/ml streptomycin, and 2 mM L-glutamine (Invitrogen) in a 5% CO 2 -humidified chamber.
Establishment of Ace-1Cells Stably Expressing
the Human DKK-1and Yellow Fluorescent Protein-Luciferase (YFP-Luc) Reporter Gene Ace-1 cells were transfected with 10 mg of pcDNA3.1(þ)/human DKK-1 (Ace-1-DKK-1) or empty vector (Ace-1-Vector) under control of the CMV promoter and 10 ml of Lipofectamine 2000 (Invitrogen). Coding sequence of human DKK-1 (accession no. NM_012242; position 155-955) was cloned into pcDNA3.1 vector (Invitrogen). Stably integrated cells were selected using 2,000 mg/ml of G418 (SigmaAldrich Co., St. Louis, MO) for 1 month. Ace-1-DKK-1 and Ace-1-Vector stable cells were transduced with the retroviral yellow fluorescent protein-luciferase (YFPLuc) dual reporter gene and 8 mg/ml polybrene by spin inoculation at 2,700 rpm for 1 hr at 328C as described previously [23] . The resulting cells were named Ace-1-DKK-1 YFP-Luc and Ace-1-Vector YFP-Luc , respectively. All the experiments were performed with pooled G418 resistant cells in both DKK-1 expressing cells and vector control groups.
DKK-1ELISA
DKK-1 concentrations were measured using the DuoSet Human DKK1 ELISA Kit as described previously [5] (R&D Systems, Minneapolis, MN, USA). The lowest standard of the assay was 62.5 pg/ml.
Cell Proliferation
Ace-1-Vector YFP-Luc cells and Ace-1-DKK-1 YFP-Luc were plated in 6-well plates at a density of 5 Â 10 3 cells per well in triplicate and cultured in DMEM/F12 supplemented with 10% fetal bovine serum, 250 U/ml penicillin, 250 mg/ml streptomycin, and 2 mM L-glutamine. The proliferation assay was performed for 8 days.
The Prostate
Total number of viable cells were counted every 2 days using the trypan blue dye exclusion method. 
Bioluminescent Imaging
Bioluminescent imaging was completed using the IVIS 100 in vivo imaging system (Caliper Life Sciences, Hopkinton, MA) as previously described [5] . The photon signal intensity was quantified using LivingImage software version 2.50 (Caliper Life Sciences).
Radiography
Radiographic images of mice were obtained immediately after sacrificing using a Faxitron cabinet radiography system LX-60 (Faxitron X-ray Corp., Wheeling, IL) at 30 kVp for 10 sec.
Histopathology
Complete necropsies were performed on mice and tissues were fixed in 10% neutral-buffered formalin at 48C for 24 hr. Bones were decalcified in 10% EDTA (pH 7.4) for 2 weeks at 48C and embedded in paraffin, sectioned (5 mm), and stained with hematoxylin and eosin (H&E) or stained for tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts (SigmaAldrich, St. Louis, MO) (kit number 386A-1KT) as previously described [5] . Bone histomorphometry was performed using the Image-Pro Plus, ver 6.3 software (Media Cybernetics, Silver Spring, MD). Tibial trabecular bone area, new woven bone area (in the metaphysis and diaphysis), cortical endosteal eroded surface, and cortical endosteal surface covered with new woven bone were measured.
Microcomputed Tomography (mCT)
Nineteen days after inoculation of Ace-1 cells, the mice were sacrificed, tibial bones were demuscled, and fixed in 10% neutral-buffered formalin at 48C for 24 hr. Formalin was replaced with 70% ethyl alcohol and transferred to 1.7 ml microcentrifuge tube for high resolution mCT scanning (Inveon, Siemens Corporation., New York, NY). Tibial bones were scanned at binning 2, 80 kV energy, 500 mA current for a total of 400 projections. Tibial images were reconstructed and analyzed for morphometry using Inveon research workplace software (IRW) (Siemens). Trabecular bone volume in the metaphyseal region and new woven bone volume in the diaphyseal region of tibial bones between the Ace-1-vector and Ace-1-DKK-1 groups were quantified using the IRW software.
Western Blotting
Total protein was extracted from subcutaneous tumors using M-PER reagent (Pierce, Rockford, IL). Approximately 50 mg of protein lysates were separated on 4-12% Tris-glycine SDS-PAGE gels (Invitrogen). Proteins were transferred to a nitrocellulose membrane and probed with primary antibodies for DKK-1 (1:1,000 dilution, R&D Systems), b-catenin (1:1,000, Abcam, Cambridge, MA) and b-actin (1:1,000, Sigma), total cJun amino-terminal kinase (JNK) (1:1,000), and phospho-JNK (1:500, Cell Signaling Technology, Inc. Danvers, MA) followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:20,000, Promega, Madison, WI) or goat antimouse antibody (1:10,000, Abcam). The signal was detected by chemiluminescent ECL Plus TM western blotting detection reagent (GE Healthcare Bio-Sciences Corp., Piscataway, NJ).
RNA Extraction and ReverseTranscriptionPolymerase Chain Reaction (RT-PCR)
Total RNA was extracted from Ace-1 cells using Trizol reagent (Invitrogen). Total RNA (1 mg) was reverse transcribed using the Superscript II First Strand cDNA synthesis kit (Invitrogen) and PCR was performed on the cDNA for the genes DKK-1, Wnt4, Wnt5A, Wnt7, LRP5, LRP6, and beta-2-microglubulin (b2M) using canine-specific primers as shown in Table I .
Collection of Conditioned Medium
Ace-1-Vector YFP-Luc and Ace-1-DKK-1 YFP-Luc cells were plated in a 6-well plate in triplicate and cultured in DMEM/F12 supplemented with 1% fetal bovine serum for 48 hr to collect conditioned medium. Conditioned medium was stored at À808C until used.
Preostoblast Mineralization Assay
ST-2 murine bone marrow osteoblast precursor cells were grown in minimum essential medium-alpha (Invitrogen) supplemented with 10% FBS, 250 U/ml penicillin, 250 mg/ml streptomycin, and 2 mM L-glutamine. At confluence, the medium was changed and all groups were supplemented with the osteoblast mineralization factors, 100 mM ascorbic acid (Fisher Scientific International, Inc., Fair Lawn, NJ), and 5 mM b-glycerophosphate (MP Biomedicals, Inc., Solon, OH). Treatment groups were treated with 50% conditioned medium from Ace-1-Vector YFP-Luc and Ace-1-DKK-1 YFP-Luc cells, respectively. Medium was changed every three days and the assay was performed for 21 days. On day 21, mineralization of the ST-2 cells was detected by von Kossa staining. Cells were fixed in 95% ethanol for 10 min and rinsed with distilled water. Cells were treated with 5% silver nitrate (SigmaAldrich, Inc., St. Louis, MO) for 20 min and rinsed with distilled water. Cells were treated with 0.5% hydroquinone (Acros Organics, Geel, Belgium) and exposed to ultraviolet light for 5 min. Cells were rinsed with distilled water and treated with 5% sodium thiosulfate (Fisher) for 5 min and rinsed in distilled water and air dried.
Transfections
To investigate the effect of Ace-1 cells on TCF reporter transcriptional activity in murine bone marrow osteoblast precursor cells (ST2), approximately 80-90% confluent ST2 cells in 6-well plates in triplicate were transfected with 1 mg of either wild-type pGL2/ TCF/Luc (Top) (Keller lab), mutant pGL2/TCFP2/Luc (FOP) constructs using 5 mL of Lipofectamine 2000 reagent (Invitrogen) for 6 hr. Then medium was removed, washed with PBS and replaced with fresh medium. Either Ace-1-Vector or Ace-1-DKK-1 cells (1 Â 10 4 ) were added to the ST2 cells transfected with TOP or FOP vector and co-cultured for 48 hr. The plasmid pbgal-Vector (200 ng) was included in each transfection reaction to correct for transfection efficiency. Luciferase activity of ST2 cells was measured with the luciferase assay system (Promega) using 20 ml of lysate. b-Galactosidase activity was measured with the luminescent b-galactosidase detection kit II (BD Biosciences, Palo Alto, CA) and bgalactosidase activity was used to normalize for transfection efficiency. Finally, wild-type TOP luciferase reporter transcriptional activity was normalized with the mutant (FOP) luciferase reporter transcriptional activity.
Statistics
All groups with normally distributed variables, unless stated otherwise, were compared by two-tailed Student's t-tests. For nonparametric data with two groups, Mann-Whitney rank sum t-tests were performed (Fig. 2) . For comparison of multiple groups, one-way ANOVA was used followed by Tukey's post hoc test to perform pair-wise comparisons (Fig. 6 ) using SigmaPlot software Ver 11.0 (Chicago, IL). Results were displayed as means AE standard deviations (SD). Data with P values < 0.05 were considered statistically significant.
RESULTS
Ace-1Prostate Cancer Cells Expressed Wnt Genes and Their Receptors
Because Wnts play an important role in oncogenesis and osteogenesis, we evaluated the expression of Wnt genes in Ace-1 cells by RT-PCR using dog-specific primers. Ace-1 cells expressed mRNAs for Wnt 4, Wnt 5A, and Wnt 7 (Fig. 1A) . Ace-1 cells also expressed DKK-1, LRP 5, and LRP 6 receptors (Fig. 1A) . Although Ace-1 cells expressed DKK-1 mRNA, secreted DKK-1 protein was below the level of detection (using the DKK-1 ELISA kit). Ace-1 cells were transfected with human DKK-1 resulting in Ace-1-DKK-1 cells stably expressing human DKK-1. The Ace-1-DKK-1 cells produced approximately 10 ng/ml/10 5 cells of DKK-1 at 72 hr as detected by ELISA (Fig. 1B) .
The Prostate To measure the effect of DKK-1 on Ace-1 tumor growth subcutaneous injections were performed with Ace-1-Vector YFP-Luc or Ace-1-DKK-1 YFP-Luc cells in athymic mice. After 6 weeks, mice were sacrificed and tumors were weighed. There was a 3.5-fold (P < 0.002) increase in tumor weight in Ace-1-DKK-1 YFP-Luc compared to the Ace-1-Vector YFP-Luc group ( Fig. 2A) . However, there was no difference in in vitro proliferation between the cell lines (data not shown). To evaluate the effect of DKK-1 on bone metastasis incidence, left ventricular intracardiac injections were performed with Ace-1-Vector YFP-Luc or Ace-1-DKK-1 YFP-Luc cells and incidence of bone metastases was measured by bioluminescent imaging on days 14, 21, and 28. The Ace-1-DKK-1 YFP-Luc cells had a significantly (P < 0.05) greater number of bone metastases compared to Ace-1-Vector YFP-Luc cells (Fig. 2B) .
Role of DKK-1in Ace-1Wnt Canonical and Noncanonical Signaling
To confirm the expression of DKK-1 in Ace-1-DKK-1 YFP-Luc tumors, total protein lysates were
The Prostate 
DKK-1Inhibits Bone Formation in Prostate Cancer
extracted and immunoblotted with antibodies to DKK1. As shown in Figure 3A , Ace-1-DKK-1 YFP-Luc tumors had marked DKK-1 protein expression and no DKK-1 was detected in the Ace-1-Vector YFP-Luc tumors. DKK-1 is shown to act primarily by interacting with LRP5/6 receptors to inhibit Wnt signaling. In order to assess the functional significance of the Wnts in Ace-1-DKK-1 YFP-Luc tumor growth, we measured the expression of b-catenin, which plays an important role in Wnt canonical signaling (Fig. 3A) . Interestingly, as shown in Figure 3A and B, there was no significant difference in the levels of b-catenin in the Ace-1-DKK-1 YFP-Luc tumors compared to Ace-1-Vector YFP-Luc tumors. b-actin was used as a loading control for protein and b-catenin expression was normalized to b-actin in Figure 3B . Because phosphorylation of JNK is one of the functional consequences of Wnt noncanonical signaling, we measured phosphorylated JNK in Ace-1-DKK-1 YFP-Luc tumors compared to Ace-1-Vector YFP-Luc tumors. As shown in Figure 3C and D, there was a significantly (P < 0.001) greater level of phospho46 (P46) JNK isoform in the Ace-1-DKK-1 YFP-Luc tumors compared to Ace-1-Vector YFP-Luc . Whereas the levels of phospho54 (P54) isoform were slightly higher in Ace-1-DKK-1 YFP-Luc tumors compared to Ace-1-Vector YFP-Luc tumors, the difference was not significant (Fig. 3C The Prostate Figure 3D and E were normalized to total JNK protein expression.
and E). Densitometry ratios in
Effect of Ace-1Conditioned Medium on InVitro Mineralization of Mouse Preosteoblast ST-2 Cells
Ace-1 Cells Conditioned Medium Did Not Induce Mineralization of Mouse ST-2 Cells In Vitro (Data Not Shown).
Radiographic Evaluation of DKK-1on Ace-1 Osteoblastic Metastases
To analyze the effect of DKK-1 on the Ace-1-induced osteoblastic metastases, radiographs of all tibial bones were made on day 19. In the Ace-1 Vector group, there was increased radio-opacity in the medullary region of the diaphysis compared to the contralateral, uninjected tibia (Fig. 4) . In contrast, DKK-1 overexpressing intramedullary tumors had marked loss of cortical and trabecular bone in the metaphyses and diaphyses of the tibias (Fig. 4) compared to the Ace-1-vector group. This suggested that DKK-1 inhibited the Ace-1-induced new bone formation in the intratibial model of bone metastases.
Histopathologic Evaluation of Intratibial Osteoblastic Metastases
To investigate the effect of DKK-1 on the osteoblastic phenotype of bone metastases, H&E-stained sections of the tibias that were injected with Ace-1 cells from both groups were examined. Intratibial injections of Ace-1 cells resulted in growth of tumor cells from the growth plate to the diaphyseal regions replacing most of the bone marrow. As evidence of the mixed osteoblastic/ osteolytic nature of Ace-1 cells, mild trabecular bone lysis was present in the metaphyses of the vector group. Additionally, the Ace-1 vector group demonstrated marked tumor-induced new woven bone formation along the endosteal surface of the tibia and in the medullary region of diaphysis resulting in an osteoblastic phenotype of bone metastasis (Fig. 5A) . In contrast, in the DKK-1 overexpressing group, marked lysis of trabecular bone and tumor-induced resorption of the cortical endosteum was present demonstrating that Ace-1 cells overexpressing DKK-1 significantly inhibited the Ace-1-induced osteoblastic phenotype (Fig. 5A) . Histomorphometric analysis showed that the trabecular bone volume in tibias with DKK-1 overexpressing Ace-1 cells was significantly decreased (approximately four-fold) compared to the vector group (Fig. 5B) . Also, the new woven bone surface area was approximately three-fold reduced in the Ace-1-DKK1 group compared to Ace-1-Vector group (Fig. 5C ).
DKK-1Decreased Tibial Endosteal Eroded Surface and Decreased New Woven Bone Formation
To investigate whether DKK-1 altered Ace-1-induced new woven bone surface and resorption surface along the tumor-tibial cortical endosteal interface, we measured the length of tibial cortical endosteal surface covered by new woven bone and eroded surfaces. Ace-1 cells overexpressing DKK-1 significantly increased the tibial endosteal eroded surface by two-fold compared to Ace-1-Vector group (Table IIA) . In addition, the DKK-1 group had markedly decreased new woven bone along (four-fold) the endosteal surface compared to the vector group (Table IIA) .
Microcomputed Tomographic Evaluation of DKK-1on Ace-1Tibial Metastases
Tibias were scanned by microcomputed tomography after fixing in neutral-buffered formalin for 24 hr. The effect of DKK-1 on Ace-1-induced new woven bone volume was measured using IRW software. Analysis of the mCT images showed that DKK-1 decreased trabecular bone volume approximately six-fold (Table IIB) and new woven bone by five-fold (Table IIB) (Fig. 6 ). This indicated that Ace-1 cells induced osteoblast activity through canonical Wnt signaling and this pathway was inhibited by DKK-1 in osteoblasts.
DISCUSSION
In the present study we have shown that Ace-1 prostate cancer cells express Wnts and Wnt receptors LRP5 and LRP6. Overexpression of DKK-1 in Ace-1 cells resulted in increased subcutaneous tumor growth and incidence of bone metastasis, but significantly decreased the osteoblastic phenotype of bone metastases. DKK-1 has been shown to increase cell proliferation and tumor growth in myeloma and HeLa cells [2, 3] . Consistent with published data, DKK-1 overexpression resulted in increased growth of subcutaneous tumors in mice. Overexpression of DKK-1 also increased the incidence of bone metastases following intracardiac injection of Ace-1 cells. DKK-1 was significantly increased in breast cancer patients with bone metastases compared to patients with nonbone metastases and healthy women [21] . Therefore, the results of this investigation indicate that DKK-1 may contribute to the increased incidence of bone metastases as reported with breast cancer.
Wnts act through both canonical and noncanonical signaling pathways [14] . In the canonical pathway, Wnts function by binding to low density LRP and frizzled receptors on the target cells to mediate Wnt signaling through b-catenin [15] . In our study there was no upregulation of b-catenin in the Ace-1-DKK-1 cells compared to the Ace-1-Vector-1 cells indicating that the signaling did not occur using the canonical pathway. In human prostate cancer, dysregulation of factors involved in the canonical Wnt pathway such as APC gene mutations [24] , downregulation or absence of GSK3b expression [25] , axin gene mutations [26] , and bcatenin mutations [27] at phosphorylation sites important for ubiquitination and further degradation were reported. In addition, mutated forms of LRP5 or LRP6 receptors were also shown to elicit constitutive canonical Wnt signaling [28, 29] . Dysregulation of any of the pathway constituents could be the cause for the absence of b-catenin induction in the Ace-1 cells [30] . Since DKK-1 overexpression did not have a significant effect on the canonical pathway in Ace-1 cells, constitutive activation of canonical Wnt signaling must be considered.
Although the Wnt noncanonical pathway is not well understood, it has been shown that JNK, Rho, and Rock pathways are involved [15] . DKK-1 increased JNK activity and its phosphorylation leading to enhanced survivability of lymphoma cells [31, 32] . Endo et al. [33] showed that DKK-1 increased the phosphorylation of JNK in the noncanonical pathway through the frizzled receptor. We investigated noncanonical signaling in Ace-1-DKK-1 cells by examining the phosphorylation of JNK. Western blots showed that the p46 isoform was markedly increased although the p54 isoform was only mildly increased. Yaccoby et al. [34] reported that inhibition of DKK-1 in myeloma using an anti-human DKK-1-neutralizing antibody significantly decreased myeloma growth and osteolysis. Therefore, DKK-1 may be contributing to the to the increased Ace-1 tumor growth seen in this study via the noncanonical pathway by upregulating phosphorylation of JNK. Since there was no difference in in vitro proliferation between the The Prostate cell lines, we speculate that the increased in vivo subcutaneous growth was due to a paracrine interaction with the tumor microenvironment.
Moreover, DKK-1 increased the incidence of Ace-1 bone metastases following intracardiac inoculation of cells. It is possible that increased survivability of Ace-1 cells through elevated p46 JNK levels might be contributing to the establishment of a greater number of bone metastases.
Secretion of Wnt 7B by prostate cancer was reported to induce osteogenic activity through the canonical signaling pathway mediated by the LRP5 receptor in immunodeficient mice and DKK-1 blocked the osteogenic activity [35] . Therefore, based on the previous data on DKK-1 mechanism of action on osteoblasts, in this model, we speculated that DKK-1 inhibited the Wnt-induced osteoblastic activity through the canonical pathway. The data from the TCF reporter transcriptional assay showed that Ace-1 cells induced activation of Wnt/TCF canonical signaling in ST2 cells. This demonstrated that Ace-1 cells likely induced osteoblastic activity through canonical signaling. Importantly, Ace-1 cells overexpressing DKK-1 inhibited Ace-1-induced canonical TCF activity in ST2 precursor osteoblasts showed that DKK-1 inhibited Ace-1-induced osteoblast activity through a paracrine mechanism. This was supported by the in vivo data that DKK-1 inhibited Ace-1-induced intratibial woven bone formation at the site of tumor cell inoculation. The in vitro mineralization assay showed that Ace-1 cell conditioned medium was not sufficient to induce differentiation of preosteoblats. However, the induction of new bone formation by Ace-1 cells in vivo suggests that cellular and paracrine interactions in the bone microenvironment are necessary for Ace-1 cells to induce new bone formation. Disruption of Ace-1 induced new bone formation by DKK-1 overexpression demonstrated that Wnt signaling was important for Ace-1-induced new bone formation in vivo.
Radiographic and histopathologic evaluation of tibias with Ace-1 cells showed that DKK-1 overexpressing cells significantly decreased new bone formation induced by Ace-1 cells as demonstrated by a marked decrease in trabecular and new woven bone area. Micro-CT imaging also demonstrated a marked decrease in trabecular and new woven bone volume. DKK-1 increased endosteal eroded surface in the tibias and decreased endosteal new woven bone surface. This demonstrated that DKK-1 secreted by Ace-1 cells not only inhibited osteoblast activity but also indirectly led to increased osteoclast activity. This data supports the previously reported findings that DKK-1 plays a significant role in determining the phenotype of human prostate cancer bone metastases [19] .
Although DKK-1 has no direct effect on osteoclastogenesis, it has been reported that DKK-1 inhibited the secretion of osteoprotegerin (OPG) and induced RANKL secretion from osteoblasts resulting in an increased RANKL:OPG ratio, which has been shown to be important for enhanced osteoclastogenesis [36] . In the current study, it is possible that DKK-1 inhibited the Ace-1-induced osteoblastic phenotype of bone metastases by directly inhibiting osteoblasts via the canonical pathway and by stimulating osteoclastogenesis indirectly through increasing the RANKL:OPG ratio.
Although DKK-1 significantly decreased Ace-1-induced new bone formation in osteoblastic metastases, its unexpected role in the increased prostate cancer growth and bone metastases incidence further necessitates investigations to clearly understand the role of Wnt canonical and noncanonical pathways in the pathogenesis of prostate cancer.
